TEVA logo

TEVA Current liabilities

annual current liabilities:

$12.80B+$549.00M(+4.48%)
December 31, 2024

Summary

  • As of today (May 30, 2025), TEVA annual total current liabilities is $12.80 billion, with the most recent change of +$549.00 million (+4.48%) on December 31, 2024.
  • During the last 3 years, TEVA annual current liabilities has risen by +$1.77 billion (+16.04%).
  • TEVA annual current liabilities is now -30.79% below its all-time high of $18.49 billion, reached on December 31, 2016.

Performance

TEVA Current liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTEVAbalance sheet metrics

quarterly current liabilities:

$11.16B-$1.64B(-12.81%)
March 31, 2025

Summary

  • As of today (May 30, 2025), TEVA quarterly total current liabilities is $11.16 billion, with the most recent change of -$1.64 billion (-12.81%) on March 31, 2025.
  • Over the past year, TEVA quarterly current liabilities has dropped by -$2.63 billion (-19.11%).
  • TEVA quarterly current liabilities is now -42.15% below its all-time high of $19.29 billion, reached on September 30, 2016.

Performance

TEVA quarterly current liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTEVAbalance sheet metrics

Current liabilities Formula

Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities

TEVA Current liabilities Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+4.5%-19.1%
3 y3 years+16.0%-3.9%
5 y5 years-6.4%-9.4%

TEVA Current liabilities Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+16.0%-19.1%+7.2%
5 y5-year-6.4%+16.0%-19.1%+7.2%
alltimeall time-30.8%>+9999.0%-42.1%>+9999.0%

TEVA Current liabilities History

DateAnnualQuarterly
Mar 2025
-
$11.16B(-12.8%)
Dec 2024
$12.80B(+4.5%)
$12.80B(-7.3%)
Sep 2024
-
$13.80B(+5.8%)
Jun 2024
-
$13.04B(-5.5%)
Mar 2024
-
$13.79B(+12.6%)
Dec 2023
$12.25B(+6.8%)
$12.25B(+7.5%)
Sep 2023
-
$11.39B(-3.8%)
Jun 2023
-
$11.84B(+13.8%)
Mar 2023
-
$10.41B(-9.2%)
Dec 2022
$11.47B(+4.0%)
$11.47B(-0.6%)
Sep 2022
-
$11.53B(+4.9%)
Jun 2022
-
$11.00B(-5.3%)
Mar 2022
-
$11.61B(+5.3%)
Dec 2021
$11.03B(-16.2%)
$11.03B(-6.7%)
Sep 2021
-
$11.82B(-6.8%)
Jun 2021
-
$12.69B(+5.0%)
Mar 2021
-
$12.09B(-8.2%)
Dec 2020
$13.16B(-3.7%)
$13.16B(+8.8%)
Sep 2020
-
$12.10B(+3.0%)
Jun 2020
-
$11.75B(-4.6%)
Mar 2020
-
$12.32B(-9.9%)
Dec 2019
$13.67B(-4.5%)
$13.67B(-3.1%)
Sep 2019
-
$14.11B(-2.4%)
Jun 2019
-
$14.45B(+3.0%)
Mar 2019
-
$14.03B(-2.1%)
Dec 2018
$14.32B(-20.1%)
$14.32B(-3.4%)
Sep 2018
-
$14.83B(+4.3%)
Jun 2018
-
$14.21B(-3.7%)
Mar 2018
-
$14.76B(-17.7%)
Dec 2017
$17.92B(-3.1%)
$17.92B(+5.8%)
Sep 2017
-
$16.94B(+9.6%)
Jun 2017
-
$15.46B(-2.8%)
Mar 2017
-
$15.90B(-14.0%)
Dec 2016
$18.49B(+42.2%)
$18.49B(-4.1%)
Sep 2016
-
$19.29B(+33.8%)
Jun 2016
-
$14.41B(+11.7%)
Mar 2016
-
$12.90B(-0.8%)
Dec 2015
$13.01B(+5.8%)
$13.01B(+0.2%)
Sep 2015
-
$12.98B(-10.3%)
Jun 2015
-
$14.47B(+16.1%)
Mar 2015
-
$12.47B(+1.4%)
Dec 2014
$12.29B(+2.7%)
$12.29B(+5.3%)
Sep 2014
-
$11.67B(-1.6%)
Jun 2014
-
$11.85B(+4.0%)
Mar 2014
-
$11.40B(-4.7%)
Dec 2013
$11.96B(-7.2%)
$11.96B(-1.6%)
Sep 2013
-
$12.16B(-5.3%)
Jun 2013
-
$12.84B(+3.9%)
Mar 2013
-
$12.36B(-4.1%)
Dec 2012
$12.89B(-5.8%)
$12.89B(+21.3%)
Sep 2012
-
$10.63B(+6.2%)
Jun 2012
-
$10.01B(-26.6%)
Mar 2012
-
$13.63B(-0.4%)
Dec 2011
$13.68B(+41.1%)
$13.68B(+19.1%)
Sep 2011
-
$11.48B(+14.3%)
Jun 2011
-
$10.05B(+13.1%)
Mar 2011
-
$8.88B(-8.3%)
Dec 2010
$9.69B
$9.69B(+4.0%)
Sep 2010
-
$9.32B(+13.9%)
Jun 2010
-
$8.18B(-1.9%)
DateAnnualQuarterly
Mar 2010
-
$8.34B(+11.2%)
Dec 2009
$7.50B(-11.5%)
$7.50B(+3.7%)
Sep 2009
-
$7.23B(-0.1%)
Jun 2009
-
$7.24B(-15.5%)
Mar 2009
-
$8.57B(+1.0%)
Dec 2008
$8.48B(+57.9%)
$8.48B(+70.2%)
Sep 2008
-
$4.98B(-8.7%)
Jun 2008
-
$5.46B(-5.1%)
Mar 2008
-
$5.75B(+7.1%)
Dec 2007
$5.37B(+31.9%)
$5.37B(+2.9%)
Sep 2007
-
$5.22B(+10.2%)
Jun 2007
-
$4.74B(+2.1%)
Mar 2007
-
$4.64B(+14.0%)
Dec 2006
$4.07B(+80.1%)
$4.07B(+3.2%)
Sep 2006
-
$3.94B(-1.2%)
Jun 2006
-
$3.99B(+8.5%)
Mar 2006
-
$3.68B(+62.9%)
Dec 2005
$2.26B(+2.5%)
$2.26B(+4.3%)
Sep 2005
-
$2.17B(+3.7%)
Jun 2005
-
$2.09B(-4.5%)
Mar 2005
-
$2.19B(-0.8%)
Dec 2004
$2.20B(+30.0%)
$2.20B(+12.0%)
Sep 2004
-
$1.97B(-5.8%)
Jun 2004
-
$2.09B(+1.8%)
Mar 2004
-
$2.05B(+21.1%)
Dec 2003
$1.69B(+11.2%)
$1.69B(-19.9%)
Sep 2003
-
$2.12B(+22.1%)
Jun 2003
-
$1.73B(+6.9%)
Mar 2003
-
$1.62B(+6.3%)
Dec 2002
$1.52B(+106.5%)
$1.52B(+74.4%)
Sep 2002
-
$874.20M(+6.4%)
Jun 2002
-
$821.80M(+15.1%)
Mar 2002
-
$714.20M(-3.2%)
Dec 2001
$738.12M(-5.8%)
$738.12M(+0.9%)
Sep 2001
-
$731.20M(+4.1%)
Jun 2001
-
$702.72M(-0.6%)
Mar 2001
-
$707.08M(-9.8%)
Dec 2000
$783.75M(+43.9%)
$783.75M(+4.8%)
Sep 2000
-
$748.20M(-16.6%)
Jun 2000
-
$896.98M(+65.3%)
Mar 2000
-
$542.52M(-0.4%)
Dec 1999
$544.58M(+1.3%)
$544.58M(-20.8%)
Sep 1999
-
$687.50M(+39.9%)
Jun 1999
-
$491.40M(-3.3%)
Mar 1999
-
$508.40M(-5.4%)
Dec 1998
$537.60M(+25.7%)
$537.60M(-0.7%)
Sep 1998
-
$541.20M(+26.7%)
Jun 1998
-
$427.30M(+4.6%)
Mar 1998
-
$408.40M(-4.5%)
Dec 1997
$427.60M(-18.0%)
$427.60M(-18.0%)
Dec 1996
$521.70M(+18.9%)
$521.70M(+18.9%)
Dec 1995
$438.70M(+82.9%)
$438.70M(+82.9%)
Dec 1994
$239.80M(+13.8%)
$239.80M(+13.8%)
Dec 1993
$210.70M(+24.1%)
$210.70M(+24.1%)
Dec 1992
$169.80M(+38.0%)
$169.80M(+38.0%)
Dec 1991
$123.00M(+5.5%)
$123.00M(+5.5%)
Dec 1990
$116.60M(+43.6%)
$116.60M(+43.6%)
Dec 1989
$81.20M(-10.4%)
$81.20M(-10.4%)
Dec 1988
$90.60M(+96.5%)
$90.60M(+96.5%)
Mar 1987
$46.10M(+5.7%)
$46.10M(+5.7%)
Mar 1986
$43.60M
$43.60M

FAQ

  • What is Teva Pharmaceutical Industries Limited annual total current liabilities?
  • What is the all time high annual current liabilities for Teva Pharmaceutical Industries Limited?
  • What is Teva Pharmaceutical Industries Limited annual current liabilities year-on-year change?
  • What is Teva Pharmaceutical Industries Limited quarterly total current liabilities?
  • What is the all time high quarterly current liabilities for Teva Pharmaceutical Industries Limited?
  • What is Teva Pharmaceutical Industries Limited quarterly current liabilities year-on-year change?

What is Teva Pharmaceutical Industries Limited annual total current liabilities?

The current annual current liabilities of TEVA is $12.80B

What is the all time high annual current liabilities for Teva Pharmaceutical Industries Limited?

Teva Pharmaceutical Industries Limited all-time high annual total current liabilities is $18.49B

What is Teva Pharmaceutical Industries Limited annual current liabilities year-on-year change?

Over the past year, TEVA annual total current liabilities has changed by +$549.00M (+4.48%)

What is Teva Pharmaceutical Industries Limited quarterly total current liabilities?

The current quarterly current liabilities of TEVA is $11.16B

What is the all time high quarterly current liabilities for Teva Pharmaceutical Industries Limited?

Teva Pharmaceutical Industries Limited all-time high quarterly total current liabilities is $19.29B

What is Teva Pharmaceutical Industries Limited quarterly current liabilities year-on-year change?

Over the past year, TEVA quarterly total current liabilities has changed by -$2.63B (-19.11%)
On this page